Epidemiological shift, seasonal variation and antimicrobial susceptibility patterns among enteric fever pathogens in south India

Tropical Doctor

Volumn 38, Issue 2, 2008, Pages 89-91

  Vidyalakshmi, K ^a   Yashavanth, R ^a   Chakrapani, M ^a   Shrikala, B ^a   Bharathi, B ^a   Suchitra, U ^a   Dhanashree, B ^a   Dominic, R M S ^a  

^a KASTURBA MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; CLINICAL DECISION MAKING; CONTROLLED STUDY; HUMAN; INCIDENCE; INDIA; INFECTION CONTROL; NONHUMAN; PARATYPHOID FEVER; SALMONELLA PARATYPHI; SEASONAL VARIATION; TERTIARY HEALTH CARE; TYPHOID FEVER; VACCINATION; ADOLESCENT; ADULT; AGED; BLOOD; CHILD; CLASSIFICATION; CULTURE MEDIUM; DRUG EFFECT; FEMALE; INFANT; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; PRESCHOOL CHILD; SALMONELLA TYPHI; SEASON;

SALMONELLA TYPHI;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; BLOOD; CHILD; CHILD, PRESCHOOL; CULTURE MEDIA; FEMALE; HUMANS; INCIDENCE; INDIA; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; SALMONELLA PARATYPHI A; SALMONELLA TYPHI; SEASONS; TYPHOID FEVER;

EID: 47549115247     PISSN: 00494755     EISSN: None     Source Type: Journal    
DOI: 10.1258/td.2007.070271     Document Type: Article

References (10)

1. Crump JA, Youssef FG, Luby SP, et al., Estimating the incidence of typhoid fever and other febrile illnesses in developing countries. Emerg Infect Dis, 2003;9:539-44
2. Herikstad H, Motarjemi Y, Tauxe RV. Salmonella surveillance: a global survey of public health serotyping. Epidemiol Infect, 2002;129:1-8
3. Palit A, Ghosh S, Dutta S, Sur D, Bhattacharya MK, Bhattacharya SK. Increasing prevalence of Salmonella enterica serotype Paratyphi-A in patients with enteric fever in a periurban slum setting of Kolkata, India. Int J Environ Health Res, 2006;16:455-9
4. Padmapriya V, Kenneth J, Amarnath SK. Re-emergence of Salmonella paratyphi A: a shift in immunity?. Natl Med J India, 2003;16:47-8
5. Harish BN, Menezes GA, Sarangapani K, Parija SC. Fluoroquinolone resistance among Salmonella enterica serovar Paratyphi A in Pondicherry. Indian J Med Res, 2006;124:585-7
6. Old DC. Salmonella. In: Collee JG, Marmion BP, Fraser AG, Simmons A, eds. Practical Medical Microbiology. 14th edn. London: Churchill Livingstone, 1996
7. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 15th Informational Supplement M100-S15. Wayne, PA, USA: Clinical and Laboratory Standards Institute, 2005
8. Vollaard AM, Ali S, van Asten HA, et al., Risk factors for typhoid and paratyphoid fever in Jakarta, Indonesia. JAMA, 2004;291:2607-15
9. Hakanen A, Kotilainen P, Jalava J, Siitonen A, Huovinen P. Detection of decreased fluoroquinolone susceptibility in Salmonellas and validation of nalidixic acid screening test. J Clin Microbiol, 1999;37:3572-7
10. Kadhiravan T, Wig N, Kapil A, Kabra SK, Renuka K, Misra A. Clinical outcomes in typhoid fever: adverse impact of infection with nalidixic acid-resistant Salmonella typhi. BMC Infect Dis, 2005;5:37